Alterity Therapeutics Limited (market cap: $40 million), a pharmaceutical company specializing in the development of therapeutic drugs, has secured A$40 million in funding to advance the development ...

Funds to be used primarily to advance development of ATH434 in Parkinsonian Disorders –– Capital raising was strongly supported by domestic and ...

Alterity Therapeutics (ATHE) has received binding commitments for a capital raising of A$40M via a two tranche placement of fully paid ordinary ...

A mixed US jobs report and Trump’s announcement of new 25 per cent tariffs on aluminium and steel imports sent Australian ...

MST Financial is managing the raise and has split it into two tranches. Shares were placed in a trading halt on Thursday.